Saudi Pharmaceutical Industries and Medical Appliances Corporation

Saudi Stock Exchange 2070.SR

Saudi Pharmaceutical Industries and Medical Appliances Corporation EBITDA Margin for the year ending December 31, 2023: 10.52%

Saudi Pharmaceutical Industries and Medical Appliances Corporation EBITDA Margin is 10.52% for the year ending December 31, 2023, a 1,215.10% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Saudi Pharmaceutical Industries and Medical Appliances Corporation EBITDA Margin for the year ending December 31, 2022 was -0.94%, a -109.66% change year over year.
Saudi Pharmaceutical Industries and Medical Appliances Corporation EBITDA Margin for the year ending December 31, 2021 was 9.77%, a -37.02% change year over year.
Saudi Pharmaceutical Industries and Medical Appliances Corporation EBITDA Margin for the year ending December 31, 2020 was 15.51%, a 182.79% change year over year.
Saudi Pharmaceutical Industries and Medical Appliances Corporation EBITDA Margin for the year ending December 31, 2019 was -18.74%, a -246.95% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Saudi Stock Exchange: 2070.SR

Saudi Pharmaceutical Industries and Medical Appliances Corporation

CEO	Mr. Jerome Christian Roger Cabannes
IPO Date	March 3, 2010
Location	Saudi Arabia
Headquarters	King Abdul Aziz Road
Employees	309
Sector	Healthcare
Industries Pharmaceuticals Clinical Trials Drugstores & Retail Pharmacies Medical Instruments Telehealth

Description

Saudi Pharmaceutical Industries and Medical Appliances develops, manufactures, and markets medicinal products and pharmaceutical formulations in the Kingdom of Saudi Arabia, Egypt, the Middle East, Morocco, and Algeria. The company is also involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics; and wholesale and retail of medicines and related products. In addition, it develops, manufactures, and sells pharmaceutical products and medical appliances; operates and maintains healthcare facilities. Further, the company engages in the research and development of medical science. The company was founded in 1986 and is headquartered in Buraydah, the Kingdom of Saudi Arabia.

Key trends

Past 5 years